Posted: October 2017 When Margaret Foti began a job as an editorial assistant for the journal Cancer Research, with a communications degree and a fervor for the biological sciences, she […] Read more
Posted: October 2017 PJ Souquet, MD was appointed President of The French Cooperative Thoracic Intergroup (Intergroupe Francophone de Cancèrologie Thoracique IFCT). Dr. Souquet, is Head of Service at the Hospices […] Read more
Posted: October 2017 The European Society for Medical Oncology (ESMO) has elected an emerging leader in thoracic oncology—and an IASLC board member—to lead the organization in 2020–2021. ESMO President- Elect […] Read more
By Heather Wakelee, MD Posted: October 2017 For most of the world, four cycles of cisplatin-based adjuvant chemotherapy is the standard of care for patients with resected stage II and […] Read more
Posted: October 2017 At the upcoming IASLC WCLC 2017 Conference, Co-Presidents Hisao Asamura, MD, and Keunchil Park, MD, PhD, will welcome delegates from more than 100 countries who will gather […] Read more
Raymond Osarogiagbon, MBBS, FACP, incoming chair of IASLC’s membership committee, will receive the 2017 Association of Community Cancer Centers Clinical Research Award. This award is given in recognition of research […] Read more
Posted: October 2017 Frances A. Shepherd, OC, OOnt, MD, FRCPC, is the recipient of two recent oncology awards: She received the Tenth Annual Addario Foundation Keynote Lecture Award, which recognizes […] Read more
• Alectinib received FDA priority review designation for first-line treatment of patients with ALK-positive, locally advanced or metastatic NSCLC. The supplemental new drug application included results from the phase III […] Read more
By Cynthia L. Kryder, MS, CCC-Sp Editor Note: IASLC Lung Cancer News is pleased to provide the following overview, which is followed by expert commentary by Dr. Heather Wakelee, Dr. […] Read more
By Julien Mazieres, MD, PhD Posted: October 2017 The standard of care for patients postresection for lung cancer is adjuvant chemotherapy, usually a platinum-based regimen.1 The deciphering of lung oncogenesis […] Read more